Letermovir Injection and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Letermovir Injection and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letermovir Injection-Rituximab Intravenous
- Letermovir Injection-Riva-Amoxicillin
- Letermovir Injection-Rivaroxaban
- Letermovir Injection-Rivastigmine
- Letermovir Injection-Rivastigmine Capsules
- Letermovir Injection-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Letermovir Intravenous
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Letermovir oral/injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Letermovir Tablets
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Letrozole
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Letrozole and ribociclib
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Leucovorin